The Patent Finder
US

Aminopyrimidines Useful as Kinase Inhibitors

US 7,820,685 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Nov 3, 2026 · Medium confidence

Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 7,767,672), so the cap could be lower.

Filed Nov 3, 2006 as application 11/592,113 · Granted Oct 26, 2010
Base term, 20 years from filing
Today
20 years from filing
Term ended Nov 3, 2026
2006 2026
Clock starts
Nov 3, 2006
Term ended
Nov 3, 2026
Granted
Oct 26, 2010
base term after the term ends fee events Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,767,672, to Nov 3, 2026. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Nov 3, 2006, when this application, 11/592,113, was filedNov 3, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,767,672)resolves to Nov 3, 2026, no earlier than this term, so no changeMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderNov 3, 2026Medium confidence

This family

US 7,820,685this patent
Nov 2026
Nov 2026
US 8,557,833In force
Jul 2027
Jul 2027
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 21, 2007
Reel 19465, frame 790
Binch, Hayley; Mortimore, Michael; Fraysse, Damien; Rutherford, AlistairVertex Pharmaceuticals IncorporatedAssignment of Assignor's Interest
Jul 10, 2014
Reel 33292, frame 311
Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLCMacquarie US Trading LLCSecurity Interest
Oct 14, 2016
reel/frame not recorded
Macquarie US Trading LLCVertex Pharmaceuticals IncorporatedRelease of Security Interest
Oct 14, 2016
reel/frame not recorded
Macquarie US Trading LLCVertex Pharmaceuticals (San Diego) LLCRelease of Security Interest
Oct 14, 2016
Reel 40357, frame 1
Macquarie US Trading LLCVertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLCRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited